Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE TrialPamela S. Douglas, Steven Grinspoon, Gerald S. Bloomfield et al.|Clinical Infectious Diseases|2021Cited by 41